Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

Clinical trial NCT02612506 · COMPLETED

Trial details

NCT number: NCT02612506
Sponsor: Shanghai HEP Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis B， Chronic

Start date: 2015-10-01
Primary completion: 2016-08-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.